<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01978249</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0277</org_study_id>
    <nct_id>NCT01978249</nct_id>
  </id_info>
  <brief_title>A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Short description for lay public, include brief statement of the study hypothesis
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Because of the difficulties of participant enrollment.
  </why_stopped>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the overall survival between patients who underwent primary tumor resection and patients who received chemotherapy without primary tumor resection</measure>
    <time_frame>2 years after allocation</time_frame>
    <description>Comparison of the overall survival between patients who underwent primary tumor resection followed by chemotherapy and patients who received chemotherapy without primary tumor resection in stage IV colorectal cancer patients with unresectable metastasis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of primary tumor related complications in the chemotherapy group and postoperative complications in the primary tumor resection followed by the chemotherapy group.</measure>
    <time_frame>2 years after allocation</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>To compare the quality of life between the two groups using the Korean version of EORTC QLQ (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire)-C30.</measure>
    <time_frame>2 years after allocation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Chemotherapy first without primary tumor resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive chemotherapy first without primary tumor resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary tumor resection followed by chemotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive primary tumor resection followed by chemotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Systemic chemotherapy</intervention_name>
    <arm_group_label>Chemotherapy first without primary tumor resection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>primary tumor resection (PTR)</intervention_name>
    <description>primary tumor resection (PTR) using open or laparoscopy or robotic surgery</description>
    <arm_group_label>Primary tumor resection followed by chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age : between 20 and 90 years old

          -  Histologically confirmed adenocarcinoma of the colon or the upper rectum

          -  Patients with resectable primary colon or upper rectal cancer and unresectable
             metastatic lesions.

          -  Patients with no primary cancer related symptoms.

          -  ECOG performance status of 0 - 2

          -  Appropriate organ functions (hepatic transaminases - less than 5 times the normal
             range; bilirubin - less than 2 times the normal range; creatinine serum - less than
             1.5 times the normal range; thrombocyte - more than 100,000/µl; neutrophil - more than
             1,500/µl)

          -  ASA score of &lt; 3

          -  An informed consent form has been signed by the patient.

        Exclusion Criteria:

          -  The patient received adjuvant chemotherapy within the past 6 months.

          -  The patient received chemotherapy for metastatic colon cancer.

          -  The patient was planning to have curative surgery for the metastatic lesions.

          -  The primary cancer is unresectable.

          -  Patients with peritoneal carcinomatosis.

          -  Patients with mid and low rectal cancer (&lt; 10cm)

          -  Patients with primary tumor related complications such as intestinal obstruction,
             intractable bleeding, and perforation, that needs to be treated.

          -  ASA score of &gt; 4

          -  The patient has chronic hepatitis or cirrhosis. An asymptomatic HBV or HCV carrier can
             participate.

          -  Patients with an active infection, which need antibiotic therapy, during the
             randomization period.

          -  Pregnant or breastfeeding women

          -  Patients who were enrolled in another clinical trial during the time of enrollment
             (within the 28 day randomization period).

          -  Patients with another different malignant tumor during the past 5 years. Patients with
             treated non-melanoma skin cancer or cervical cancer can be enrolled in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Surgery, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2013</study_first_posted>
  <last_update_submitted>September 5, 2016</last_update_submitted>
  <last_update_submitted_qc>September 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer</keyword>
  <keyword>Primary tumor resection</keyword>
  <keyword>Chemotherapy</keyword>
  <keyword>Overall survival</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

